Abiopharma

New Form SCHEDULE 13G/A - Fortrea Holdings Inc. Filed: 2025-05-15 AccNo: 0000010742-25-000009 Size: 6 KB

New Form 10-Q - Aptevo Therapeutics Inc. Filed: 2025-05-15 AccNo: 0000950170-25-072622 Size: 6 MB

New Form 8-K - REVIVA PHARMACEUTICALS HOLDINGS, INC. Filed: 2025-05-15 AccNo: 0001437749-25-017185 Size: 304 KB Item 2.02: Results of Operations and Financial Condition Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

New Form 4 - VERTEX PHARMACEUTICALS INC / MA Filed: 2025-05-15 AccNo: 0000875320-25-000196 Size: 5 KB

New Form 6-K - CureVac N.V. Filed: 2025-05-15 AccNo: 0001104659-25-049433 Size: 31 KB

New Form 5 - IGC Pharma, Inc. Filed: 2025-05-15 AccNo: 0001185185-25-000495 Size: 11 KB

New Form 10-Q - Zivo Bioscience, Inc. Filed: 2025-05-15 AccNo: 0001654954-25-005748 Size: 2 MB

CureVac Receives Additional Positive Validity Decision from European Patent Office in Ongoing Litigation Against BioNTech SE

New Form 8-K - Fortress Biotech, Inc. Filed: 2025-05-15 AccNo: 0001558370-25-007878 Size: 481 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

New Form 8-K - Bausch Health Companies Inc. Filed: 2025-05-15 AccNo: 0001193125-25-120802 Size: 145 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

New Form SCHEDULE 13G/A - LENSAR, Inc. Filed: 2025-05-15 AccNo: 0001641172-25-010908 Size: 11 KB

New Form ARS - DBV Technologies S.A. Filed: 2025-05-15 AccNo: 0001193125-25-120803 Size: 10 MB

New Form SCHEDULE 13G/A - HARVARD BIOSCIENCE INC Filed: 2025-05-15 AccNo: 0001641172-25-010912 Size: 8 KB

New Form 5 - IGC Pharma, Inc. Filed: 2025-05-15 AccNo: 0001185185-25-000494 Size: 14 KB

New Form 4 - Organon & Co. Filed: 2025-05-15 AccNo: 0001821825-25-000037 Size: 5 KB